Covalon Technologies Ltd.
COV.V
TSX
Weiss Ratings | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Reward Grade | C | |||
Rating Factors | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Fair | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.02 | |||
Price History | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.96% | |||
30-Day Total Return | -13.33% | |||
60-Day Total Return | -24.42% | |||
90-Day Total Return | -24.42% | |||
Year to Date Total Return | -16.93% | |||
1-Year Total Return | 100.00% | |||
2-Year Total Return | 19.27% | |||
3-Year Total Return | 20.93% | |||
5-Year Total Return | 73.33% | |||
52-Week High % Change | -45.81% | |||
52-Week Low % Change | 140.21% | |||
Price | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $4.30 | |||
52-Week Low Price | $0.97 | |||
52-Week Low Price (Date) | Apr 24, 2024 | |||
52-Week High Price (Date) | Nov 18, 2024 | |||
Valuation | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 44.33M | |||
Enterprise Value | 32.73M | |||
Price/Earnings (TTM) | 17.91 | |||
Earnings Per Share (TTM) | 0.13 | |||
Earnings Per Share Growth | -183.56% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 2.58 | |||
Price/Book (Q) | 3.00 | |||
Enterprise Value/Revenue (TTM) | 1.29 | |||
Price | $2.60 | |||
Enterprise Value/EBITDA (TTM) | 8.28 | |||
Enterprise Value/EBIT | 9.08 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 28.04M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 905 568 8400 | |||
Address | 1660 Tech Avenue Mississauga, ON L4W 5S7 | |||
Website | www.covalon.com | |||
Country | Canada | |||
Year Founded | 2004 | |||
Profitability | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 14.23% | |||
Profit Margin | 13.63% | |||
Management Effectiveness | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 10.97% | |||
Return on Equity | 19.91% | |||
Income Statement | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 25.32M | |||
Total Revenue (TTM) | 25.32M | |||
Revenue Per Share | $0.90 | |||
Gross Profit (TTM) | 15.39M | |||
EBITDA (TTM) | 3.95M | |||
EBIT (TTM) | 3.60M | |||
Net Income (TTM) | 3.45M | |||
Net Income Avl. to Common (TTM) | 3.45M | |||
Total Revenue Growth (Q YOY) | 70.20% | |||
Earnings Growth (Q YOY) | 237.66% | |||
EPS Diluted (TTM) | 0.13 | |||
EPS Diluted Growth (Q YOY) | 212.60% | |||
Balance Sheet | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 12.16M | |||
Cash Per Share (Q) | $0.43 | |||
Total Current Assets (Q) | 22.27M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 21.30M | |||
Current Ratio (Q) | 8.115 | |||
Book Value Per Share (Q) | $0.78 | |||
Total Assets (Q) | 24.20M | |||
Total Current Liabilities (Q) | 2.74M | |||
Total Debt (Q) | 545.40K | |||
Total Liabilities (Q) | 2.89M | |||
Total Common Equity (Q) | 21.30M | |||
Cash Flow | COV.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -279.30K | |||
Cash from Financing (TTM) | 3.67M | |||
Net Change in Cash (TTM) | 6.72M | |||
Levered Free Cash Flow (TTM) | -122.50K | |||
Cash from Operations (TTM) | 2.55M | |||